article thumbnail

Machine learning models for atrial fibrillation detection in primary care using electronic health records: systematic review [Cardiovascular disease]

Annals of Family Medicine

Machine learning (ML) models offer potential for improved detection of AFib from electronic health records (EHR). We searched seven databases from inception to May 2023. Population Studied: Adults without a prior AFib diagnosis. Study Design and Analysis: This systematic review followed PRISMA guidelines.

article thumbnail

Pain-Related Medication in Adults with Intellectual Disability: a systematic review [Pain management]

Annals of Family Medicine

Search strategy developed for six medical databases (2000-March 2023), key terms of ID, pain, analgesia, medication. Measures: Varied by study design; self/carer-report or electronic health records (EHR). There was over-prescribing of antipsychotic medication without an associated diagnosis. Narrative synthesis of findings.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Cardiovascular risk management of patients with depression in Dutch general practices [Behavioral, psychosocial, and mental illness]

Annals of Family Medicine

Study design and analysis: A retrospective matched cohort study using data from more than 70 Dutch general practices collected from 2015 until 2023. Setting or Dataset: The Academic GP Developing Network Database (AHON), containing data from the electronic patient file of more than 460,000 patients was used for analysis.

article thumbnail

Hepatitis C Micro-elimination Using Patient Navigation In a Regional Healthcare System [Infectious diseases (not respiratory tract)]

Annals of Family Medicine

Micro-elimination projects aim to selectively foster diagnosis, treatment and reinfection of high priority demographic groups. Context: Hepatitis C virus (HCV) disproportionately impacts persons with substance use and mental health disorders within the United States.

article thumbnail

A Long Time Coming: DEA Regs Finally Authorize Schedule II Prescription Partial Fills

FDA Law

Now, in July 2023, DEA has finally issued its final rule amending its regulations for partial filling of prescriptions for schedule II substances. 46,983 (July 21, 2023). For electronic prescriptions, the quantity dispensed, date dispensed, and the dispenser must be linked to each electronic prescription record.

article thumbnail

Prescribing Red Flags and Suspicious Controlled Substance Orders: Current Cautionary Tales

FDA Law

11, 2023 ( DOJ Press Release ). 6, 2023 ( DOJ Press Release ). Prescriptions Containing No Diagnosis or Intended Use Controlled substance prescriptions issued with a non-specific diagnosis or no diagnosis. Several weeks later, also based on ability to pay, the U.S. Complaint ¶ 60. Complaint ¶ 61.

article thumbnail

Sweet! A Metabolic Disorders focused podcast episode

PEMBlog

She is a member of the Clinical Genome Resource Inborn Errors of Metabolism (IEM) Clinical Domain Working Group, where as a biocurator she assesses the pathogenicity of variants in IEM-associated genes to facilitate expedited genetic diagnosis for IEMs. Updated 2023 Jul 17]. Inborn errors of metabolism in infancy: a guide to diagnosis.